Jeffrey Vernimb

Jeffrey Vernimb is a declared insider of Moberg Pharma AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 7 June 2017 to 12 March 2018, the count stands at 4 filings.

The open-market record is one-sided, with 4 purchases worth €40k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2018: 2 purchases and no sales on the market.

In size, the median ticket on the buying side is €12k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +4.7%. These figures describe past trades and do not predict future prices.

Most recently, on 16 March 2018, the filings show an open-market purchase worth €9,920 in Moberg Pharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.